(RGC) Regencell Bioscience - Performance 643.3% in 12m
Compare RGC with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
12.89%
#33 in Group
Rel. Strength
99.86%
#12 in Universe
Total Return 12m
643.33%
#4 in Group
Total Return 5y
176.10%
#19 in Group
P/E -
(unknown) Percentile in Group
P/E Forward -
(unknown) Percentile in Group
PEG -
(unknown) Percentile in Group
FCF Yield 0.47%
(unknown) Percentile in Group
12m Total Return: RGC (643.3%) vs XBI (-16.6%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-2.46% | 18.3% | 247% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
-1.02% | 34.4% | 231% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-3.78% | 22.7% | 39.9% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
| AMGN NASDAQ Amgen |
-1.24% | 11.7% | 74.3% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
| LONN SW Lonza |
-6.23% | 2.39% | 39.1% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
| NBIX NASDAQ Neurocrine Biosciences |
-6.53% | -24.3% | 24.7% | 35.3 | 23.4 | 0.27 | 61.5% | 31.6% |
| BIM PA Biomerieux |
-0.09% | 14.3% | 16.2% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
| KMDA NASDAQ Kamada |
1.5% | 22.9% | 20.5% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: RGC vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RGC
| Total Return (including Dividends) | RGC | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 615.63% | -8.69% | -3.62% |
| 3 Months | 501.45% | -14.60% | -3.76% |
| 12 Months | 643.33% | -16.59% | 8.80% |
| 5 Years | 176.10% | 4.83% | 143.09% |
| Trend Score (consistency of price movement) | RGC | XBI | S&P 500 |
| 1 Month | 75.2% | -45.3% | -17.5% |
| 3 Months | 29.5% | -67.7% | -55.3% |
| 12 Months | 14.0% | -5.2% | 84.8% |
| 5 Years | -68.3% | -49.6% | 84.4% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #2 | 684% | 642% |
| 3 Month | #1 | 604% | 525% |
| 12 Month | #4 | 791% | 583% |
| 5 Years | #7 | 344% | 101% |
FAQs
Does RGC Regencell Bioscience outperforms the market?
Yes,
over the last 12 months RGC made 643.33%, while its related Sector, the SPDR S&P Biotech (XBI) made -16.59%.
Over the last 3 months RGC made 501.45%, while XBI made -14.60%.
Over the last 3 months RGC made 501.45%, while XBI made -14.60%.
Performance Comparison RGC vs Indeces and Sectors
RGC vs. Indices RGC is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -29.3% | 619% | 439% | 635% |
| US NASDAQ 100 | QQQ | -27.6% | 620% | 439% | 636% |
| US Dow Jones Industrial 30 | DIA | -30.3% | 618% | 438% | 635% |
| German DAX 40 | DAX | -29.2% | 618% | 421% | 621% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -30.3% | 615% | 447% | 634% |
| Hongkong Hang Seng | HSI | -32.1% | 613% | 443% | 625% |
| India NIFTY 50 | INDA | -29.9% | 609% | 449% | 643% |
| Brasil Bovespa | EWZ | -30.7% | 607% | 445% | 655% |
RGC vs. Sectors RGC is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -28.4% | 620% | 431% | 625% |
| Consumer Discretionary | XLY | -28.7% | 621% | 437% | 633% |
| Consumer Staples | XLP | -35.7% | 617% | 438% | 633% |
| Energy | XLE | -32.6% | 608% | 431% | 641% |
| Financial | XLF | -30.4% | 619% | 427% | 623% |
| Health Care | XLV | -30.5% | 619% | 444% | 644% |
| Industrial | XLI | -29.8% | 617% | 440% | 636% |
| Materials | XLB | -31.5% | 616% | 447% | 648% |
| Real Estate | XLRE | -33.2% | 619% | 442% | 632% |
| Technology | XLK | -27.1% | 620% | 443% | 643% |
| Utilities | XLU | -34.6% | 615% | 439% | 618% |
| Aerospace & Defense | XAR | -26.9% | 616% | 435% | 626% |
| Biotech | XBI | -21.6% | 624% | 458% | 660% |
| Homebuilder | XHB | -29.4% | 617% | 459% | 654% |
| Retail | XRT | -30.9% | 618% | 445% | 653% |